Röwert-Huber J, Patel M J, Forschner T, Ulrich C, Eberle J, Kerl H, Sterry W, Stockfleth E
Department of Dermatology, Charité, Skin Cancer Center Charité, University Hospital of Berlin, Berlin, Germany.
Br J Dermatol. 2007 May;156 Suppl 3:8-12. doi: 10.1111/j.1365-2133.2007.07860.x.
The term actinic keratosis (AK) describes a sun-induced, clinical erythematous lesion covered with scale, but does not provide an understanding of the biology or histopathology of the lesion. Consequently, several classification systems for AK have been suggested, but as yet no consensus has been reached. These systems strive to correlate the pathological and clinical features to better provide physicians with the most accurate information to enable correct decisions to be made regarding treatments, Prognosis and metastatic potential. AK is a clinical description that has a histological diagnosis consistent with squamous cell carcinoma (SCC) in situ. We recommend an AK classification system that describes these lesions as squamous cell carcinomas (SCCs), using the terminology 'early in situ SCC Type AK I', 'early in situ SCC type AK II' and 'in situ SCC Type AK III', there by giving clinicians better guidance for diagnosis and specific treatment recommendations.
光化性角化病(AK)这一术语描述的是一种由阳光引起的、临床可见的红斑性病变,表面覆盖有鳞屑,但并未对该病变的生物学特性或组织病理学作出阐释。因此,人们提出了多种AK分类系统,但至今尚未达成共识。这些系统力求将病理特征与临床特征相关联,以便更好地为医生提供最准确的信息,使其能够就治疗、预后和转移潜能做出正确决策。AK是一种临床描述,其组织学诊断与原位鳞状细胞癌(SCC)相符。我们推荐一种AK分类系统,该系统将这些病变描述为鳞状细胞癌(SCC),采用“早期原位SCC AK I型”“早期原位SCC AK II型”和“原位SCC AK III型”这样的术语,从而为临床医生的诊断和具体治疗建议提供更好的指导。